For GHK-Cu, innovations in delivery methods such as nanotechnology, microneedling, and liposomal systems may allow for more efficient and deeper absorption into the skin, amplifying its anti-aging effects and collagen-boosting properties
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, whereas semaglutide acts on GLP-1 receptors alone and tirzepatide targets both GIP and GLP-1 receptors
Clinical data shows that patients on GLP-1 therapy lose approximately 10-15% of baseline body weight over 6 months, with continued improvements through month 12
He lost about 170 pounds, trains in a garage gym, and writes DadStrengthDaily from personal experience, citing primary sources where he can
keep intake to no more than 6 g daily